Arpa Garay is President, Global Pharmaceuticals, Commercial Analytics and Digital Marketing at Merck. In addition to leading data analytics and digital marketing worldwide for headquarters and country operations, she also leads the commercialization of in-line and pipeline assets as well as business development across specialty, hospital and chronic care businesses, at MSD the tradename of Merck & Co., Inc, Kenilworth, NJ, USA. Prior to this appointment, Arpa was Senior Vice President, US Vaccines, leading a cross-functional organization to improve public health and deliver on business objectives across a portfolio of pediatric, adolescent, and adult vaccines. She was also the Managing Director of Norway, where she worked closely with the government on healthcare policy, developed innovative approaches to securing patient access, and led the subsidiary to become the number-one pharmaceutical company in the country. She has worked across a range of therapeutic areas and spearheaded multiple product launches. In addition to her commercial roles, Arpa led the corporate ten-year global scenario planning and worked on the US integration of MSD and Schering-Plough. Before joining MSD in 2006, Arpa worked at Bristol-Myers Squibb and as a strategy consultant at the Monitor Group (now Monitor Deloitte). She has been externally recognized for her leadership as Fortune’s Most Powerful Women: Next Gen, Business Insider’s Top 30 under 40 in BioPharma, and Philadelphia Business Journal’s Top 40 under 40 business leaders. Arpa holds a Bachelor of Science degree in Economics from the Massachusetts Institute of Technology, where she focused on medicine, public health and public policy.